Recombinant Human CDH18 Protein，His

CDH18, or Cadherin 18, is a member of the cadherin superfamily, which is essential for cell adhesion and is vital in processes such as tissue development and maintenance. The study of CDH18 recombinant protein has gained significant attention due to its potential role in neurodevelopmental processes and various neuropsychiatric disorders. Research indicates that CDH18 is prominently expressed in the central nervous system, particularly in regions associated with cognitive functions and synaptic plasticity. Its involvement in the formation and stabilization of synapses suggests that disruptions in its expression or function could be linked to conditions like autism spectrum disorders and schizophrenia. Moreover, understanding the structural and functional properties of CDH18 through recombinant protein studies can provide insights into its mechanistic roles in cell-cell interactions and signaling pathways. This research is pivotal to unraveling the complexities of neurological diseases and could lead to the development of targeted therapies aimed at restoring normal cadherin function. Furthermore, CDH18's unique expression pattern and interaction with other signaling molecules position it as a potential biomarker for neurodevelopmental research. Hence, the exploration of CDH18 recombinant protein not only enhances our understanding of fundamental biological processes but also opens avenues for innovative therapeutic strategies in treating neurodevelopmental disorders.